Detalhe da pesquisa
1.
[A Case of Lung Adenocarcinoma Presenting with Leptomeningeal Carcinomatosis Successfully Treated with Afatinib after Erlotinib-Induced Hepatotoxicity].
Gan To Kagaku Ryoho
; 44(7): 595-597, 2017 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-28790264
2.
[A Retrospective Study Analyzing the Clinical Course of Patients with Non-Small Cell Lung Cancer Receiving Local or Systemic Therapy after Post-Operative Recurrence].
Gan To Kagaku Ryoho
; 44(9): 767-770, 2017 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-28912406
3.
Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective study.
Support Care Cancer
; 23(7): 2129-33, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25547482
4.
Association of serum adiponectin with asthma and pulmonary function in the Japanese population.
Endocr J
; 62(8): 695-709, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25985757
5.
[Efficacy and toxicity of pemetrexed monotherapy for previously untreated elderly patients with non-squamous cell lung cancer with wild-type(or unknown)EGFR status].
Gan To Kagaku Ryoho
; 41(7): 849-52, 2014 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-25131870
6.
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.
Anticancer Res
; 44(3): 1241-1245, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423671
7.
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
In Vivo
; 38(3): 1509-1511, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38688637
8.
Comparison of the efficacy of first/secondgeneration EGFRtyrosine kinase inhibitors and osimertinib for EGFRmutant lung cancer with negative or low PDL1 expression.
Mol Clin Oncol
; 20(6): 43, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38756869
9.
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
Sci Rep
; 13(1): 10807, 2023 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402763
10.
Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors.
Anticancer Res
; 43(7): 3241-3246, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351972
11.
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumorinfiltrating CD68positive cell counts in patients with EGFRmutant nonsmall cell lung cancer.
Mol Clin Oncol
; 18(5): 38, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035471
12.
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
Thorac Cancer
; 14(17): 1618-1623, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101081
13.
Association of Tumor PD-L1 Expression With Time on Treatment Using EGFR-TKIs in Patients With EGFR-Mutant Non-small Cell Lung Cancer.
Cancer Diagn Progn
; 2(3): 324-329, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35530643
14.
Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer.
Tumori
; 107(6): 536-541, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847814
15.
Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 Expression.
Cancer Diagn Progn
; 1(3): 173-177, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35399317
16.
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.
In Vivo
; 35(3): 1687-1692, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910853
17.
Relationship between Patient Characteristics and the Timing of Provision of Explanation about DNAR to Patients with Advanced Lung Cancer.
Intern Med
; 59(23): 2989-2994, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759584
18.
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy.
Diagnostics (Basel)
; 10(12)2020 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33255696
19.
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy.
Pathol Oncol Res
; 26(1): 327-333, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232703
20.
Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor.
Anticancer Res
; 39(12): 6887-6893, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31810958